Please assess the completion status of the following clinical trial:

Trial Title: RUPP PI PDD: Drug and Behavioral Therapy for Children With Pervasive Developmental Disorders

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Autistic Disorder, Asperger's Disorder, or Pervasive Developmental Disorder not otherwise specified~* Weight \> 30 lbs~* IQ \>= 35 or mental age of at least 18 months~Exclusion Criteria:~* Psychotic Disorder~* History of intolerance or nonresponse to risperidone~* Pregnancy~* History of neuroleptic malignant syndrome

- Gender: ALL
- Minimum Age: 4 Years
- Maximum Age: 13 Years
- Healthy Volunteers: f

Study Arms:
- risperidone plus parent management training (Type: ACTIVE_COMPARATOR): None
- risperidone only (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).